You are here:

  1. NICE
  2. NICE Guidance
  3. Published Guidance

Migalastat for treating Fabry disease

  • Highly specialised technologies guidance
  • Reference number: HST4
  • Published:  22 February 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Final evaluation determination
  3. Evaluation consultation
  4. Invitation to participate
  5. Draft scope documents

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 235 KB)

    Published:
    22 February 2017

Final evaluation determination

  • Final evaluation determination

  • Final evaluation determination document (PDF 417 KB)

    Published:
    03 January 2017
  • Committee papers (PDF 517 KB)

    Published:
    03 January 2017
  • Public committee slides (PDF 252 KB)

    Published:
    17 January 2017

Evaluation consultation

  • Evaluation consultation

  • Evaluation consultation document (PDF 285 KB)

    Published:
    18 October 2016
  • Committee papers (PDF 7.69 MB)

    Published:
    18 October 2016

Invitation to participate

  • Equality impact assessment (Scoping) (PDF 122 KB)

    Published:
    21 January 2016
  • Final scope (PDF 109 KB)

    Published:
    21 January 2016
  • Final matrix (PDF 108 KB)

    Published:
    21 January 2016
  • NICE's response to comments on the draft scope and provisional matrix (PDF 162 KB)

    Published:
    05 July 2016

Draft scope documents

  • Draft scope (pre-referral) (PDF 114 KB)

    Published:
    29 January 2016
  • Provisional matrix (pre-referral) (PDF 109 KB)

    Published:
    29 January 2016